Pola penggunaan obat anti diabetes mellitus tipe-II pada pasien rawat inap di RSUD Praya tahun 2021
DOI:
10.29303/sjp.v5i1.254Downloads
Abstract
Diabetes mellitus is a metabolic disease characterized by hyperglycemia due to abnormalities in insulin secretion. The prevalence of people with diabetes mellitus in Indonesia reached 6.2% per year in 2020 and ranks 7th in the world with 8.5 million people. Based on the results of observations at the Praya Hospital in 2021, type-II diabetes mellitus is the 4th highest-order disease suffered by the community, especially Central Lombok Regency, with a total incidence of 131 patients. This study aims to determine the pattern of drug use and HbA1c profile in patients with type-II diabetes mellitus in the inpatient installation of Praya Hospital in 2021. This study was retrospective, using the Nonprobability Sampling method, namely the type of purposive sampling so that a sample of 96 medical records of diabetes mellitus patients was obtained type-II. The data is presented as pie charts and tables in percentages, which were analyzed using Microsoft Excel and SPSS version 25. From the results of this research, it was found that the pattern of drug use at Praya Hospital in 2021 was given the highest from each group namely the oral antidiabetic drug group (OAD) was in the Biguanid class with 61 drugs (8,13%), while insulin drugs were in the Rapid-Acting class with 343 drugs (45,73%), and the OAD + Insulin combination with 119 drugs (15,87%). For the HbA1c profile, high HbA1c levels were found in 76 patients (79%). This shows that blood glucose control is not reasonable. Based on the study's results, the recommended recommendation is that patients routinely control blood sugar and be educated on the accuracy of drug use to control blood sugar.
Keywords:
Diabetes mellitus, HbA1c, pattern of drug useReferences
Al Amin, M. (2017). Klasifikasi Kelompok Umur Manusia Berdasarkan Analisis Dimensi Fraktal Box Counting dari Citra Wajah dengan Deteksi Tepi Canny. MATHunesa (Jurnal Ilmiah Matematika), 2(6).
American Diabetes Association. (2017). Standards of Medical Care in Diabetes 2017. (40). USA: ADA.
Annisa, BS., Puspitasari, CE., & Aini, SR. (2021). Profil penggunaan obat anti diabetes pada pasien diabetes mellitus tipe 2 di instalasi rawat jalan RSUD Provinsi NTB tahun 2018. Sasambo Journal of Farmasi, 2(1), 37-41.
Arini, A., &Dwipayana, P. (2020). Hubungan Kadar HbA1c Terhadap Terapi Obat Anti diabetes Oral dan Kombinasi Obat Anti diabetes Oral-Insulin pada Penderita DM Tipe-2 di Poliklinik Diabetes RSUP Sanglah Denpasar Tahun 2016. Jurnal Medika Udayana, 9(9), 94-99.
Asmiati, E., Kusuma, S. N. A, Hidayati, I. R., & Atmadani, R. N. (2022). Analisis Penggunaan Glibenklamid dan Glimepirid Berdasarkan Peresepan Obat Menggunakan Metode ATC/DDD. Journal Of Pharmacy Science and Technology, 3(1), 172-180.
Departemen Kesehatan Republik Indonesia. (2020). MIMS Indonesia Petunjuk Konsultasi, Edisi 20. Asia Jakarta: UBM Medica.
Fatimah, R. N. (2015). Diabetes melitus tipe 2. J majority, 4(5), 93-101.
Hardianto, D. (2020). Telaah Komprehensif Diabetes Mellitus: Klasifikasi, Gejala, Diagnosis, Pencegahan, dan Pengobatan. J Bioteknol Biosains Indonesia, 7(2), 304-317.
Haryati, A. I., & Tyas, T. A. W. (2022). Perbandingan Kadar HbA1c pada Pasien Diabetes Melitus Tipe 2 yang Disertai Hipertensi dan Tanpa Hipertensi di Rumah Sakit Umum Daerah Duri, Mandau, Bengkalis, Riau. Jurnal Kedokteran dan Kesehatan, 18(1), 33-40.
Husnawati, Lukman, A., & Ardiansyah, I. (2016). Sistem Implementasi Sistem Penyimpanan Obat di Puskesmas Rawat Inap Sidomulyo Kota madya Pekanbaru. Jurnal Sekolah Tinggi Ilmu Farmasi, 1(1), 1-6.
Husni, H., Wahyudin, E., & Kasim, H. (2022). Hubungan Tekanan Darah Sistolik dengan Kadar HbA1c pada Pasien Hipertensi dan Diabetes Mellitus Tipe II di RS UNHAS Makassar. Majalah Farmasi dan Farmakologi, 26(2), 84-87.
International Diabetes Federation Indonesia. (2017). Diabetes Atlas (Seventh Edition). International Diabetes Federation Indonesia.
Jelantik, I.G.M.G., & Haryati E. (2016). Hubungan Faktor Resiko Umur, jenis Kelamin, Kegemukan dan Hipertensi dengan kejadian Diabetes Mellitus Tipe II di Wilayah Kerja Puskemas Mataram. Media Bina Ilmiah. 1(1).
Kementerian Kesehatan Republik Indonesia. (2018). Riset Kesehatan Dasar; RISKESDAS. Jakarta: Balitbang Kemenkes RI.
Nasution, F., Andilala, A., & Siregar, A. A. (2021). Faktor Risiko Kejadian Diabetes Mellitus. Jurnal Ilmu Kesehatan, 9(2), 94-102.
Nur Isnaini, R. (2018). Faktor risiko mempengaruhi kejadian Diabetes mellitus tipe dua. Jurnal Kebidanan Dan Keperawatan Aisyiyah, 14(1),59-68.
Pangestika, H. Ekawati, D., & Murni, N. S. (2022). Faktor-faktor yang Berhubungan dengan Kejadian Diabetes Mellitus Tipe-2. Jurnal ‘Aisyiyah Medika, 7(1), 132-150.
PERKENI. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Mellitus Tipe-2 Dewasa di Indonesia. Jakarta: PB PERKENI.
Putra, P. H., & Permana, D. (2021). Penggunaan dan Pemilihan Obat Anti diabetes pada Pasien Diabetes Rawat Jalan di Puskesmas KarangRejo Tarakan. Yarsi Journal of Pharmacology, 2(1), 38-45.
Rasdianah, N., & Gani, A. S. W. (2021). Interaksi Obat pada Pasien Diabetes Mellitus Tipe-2 dengan Penyakit Penyerta di Rumah Sakit Otanaha Kota Gorontalo. Indonesian Journal of Pharmaceutical Education (e-Journal), 1(1), 39-46.
Rosyadi, A. (2022). Evaluasi Pola Peresepan Obat Pasien Hipertensi Dengan Diabetes Mellitus Pada Pasien Geriatri Pengguna JKN. Jurnal Bina Cipta Husada, 18(2), 45-58.
Santosa, A., Trijayanto, P.A., & Endiyono. (2017). Hubungan Riwayat Garis Keturunan dengan Usia Terdiagnosis Diabetes Mellitus Tipe-II. Jurnal Universitas Muhammadiyah Magelang, 1(1), 1-6.
Suandy, S., Lumbantobing, A.N., Rohen, R., Chairul, M., Dewani, Y., & Tarigan, S.B. (2022). Indeks Massa Tubuh dan Kadar HbA1c pada Pasien Diabetes Mellitus Tipe-II. Jurnal Prima Medika Sains, 4(1), 17-20.
Suharni, A. Z., & Kusnadi, D. T. (2021). Kadar HbA1C Pada Pasien Diabetes Melitus Tipe 2 dengan Komplikasi Neuropati Diabetik di RSI Siti Rahmah Padang Tahun 2019-2020. Baiturrahmah Medical Journal, 1(2), 32-36.
Turisia, N. A., Aini, S. R., & Dewi, N. M. A. R. (2019). Gambaran Penggunaan Obat Anti diabetes Mellitus Berdasarkan Indikator WHO di Instalasi Rawat Jalan RSUD Provinsi NTB Periode 2018. Natural B, Journal of Health and Environmental Sciences, 5(2), 059-062.
Wulandari, I. A. T., Herawati, S., &Wande, I. N. (2020). Gambaran kadar HbA1c pada pasien diabetes melitus tipe II di RSUP Sanglah periode Juli-Desember 2017. Jurnal Medika Udayana, 9(1), 71-75.
License
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Sasambo Journal of Pharmacy (SJP), agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Lisensi Creative Commons Atribusi 4.0 Internasional. This license allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Sasambo Journal of Pharmacy
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
